Sorrento Presents Preliminary Results of STI-2020 Against COVID-19
Shots: The NMPS has approved the combination of MAA for Optune + temozolomide to treat patients with newly diagnosed GBM and a monothx. for patients with recurrent GBM. The P-III study in newly diagnosed GBM showed adding Optune to CT more than doubled the 5yrs. OS rate Tumor Treating Fields therapy receives the US FDA’s […]Read More
